HIV-1 and hepatitis B virus: time for a re-think?

被引:1
作者
Ripamonti, D [1 ]
Maggiolo, F [1 ]
Suter, F [1 ]
机构
[1] Osped Riuniti Bergamo, Div Malattie Infett, I-24128 Bergamo, Italy
关键词
D O I
10.1016/S0140-6736(04)16067-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1400 / 1400
页数:1
相关论文
共 5 条
[1]   Lamivudine as initial treatment for chronic hepatitis B in the United States [J].
Dienstag, JL ;
Schiff, ER ;
Wright, TL ;
Perrillo, RP ;
Hann, HWL ;
Goodman, Z ;
Crowther, L ;
Condreay, LD ;
Woessner, M ;
Rubin, M ;
Brown, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) :1256-1263
[2]  
Lok ASF, AASLD PRACTICE GUIDE
[3]  
*PAN CLIN PRACT TR, 2003, GUID US ANT AG HIV I
[4]  
SYKES A, 2002, 9 C RETR OPP INF FEB
[5]   Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation [J].
Van Bömmel, F ;
Schernick, A ;
Hopf, U ;
Berg, T .
GASTROENTEROLOGY, 2003, 124 (02) :586-587